GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain

January 08, 2025 02:30 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

PISCATAWAY, N.J., Jan. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This milestone marks significant progress in GenScript's journey of fulfilling its social responsibility and advancing sustainable development, while underscoring the company's commitment to building a healthier, greener, and more ethical industry ecosystem.

PSCI is a leading global association dedicated to fostering responsible value chains in the pharmaceutical and healthcare industries. Its core mission is to address challenges within the pharmaceutical supply chain and enhance performance in areas such as ethics, human rights and labor, health and safety, environment and related management systems. Through cross-industry collaboration, PSCI drives its partners toward achieving excellence in ESG (Environmental, Social, and Governance) performance. PSCI's Principles for Responsible Supply Chain Management, along with its implementation guidelines and assessment tools, are widely recognized and respected across the global pharmaceutical sector.

"As a responsible global enterprise in life sciences and biotechnology, GenScript is honored to become a PSCI Supplier Partner," said Sherry Shao, rotating CEO of GenScript Biotech Corporation. "Across our four key business areas—life sciences services and products, biologics contract development and manufacturing (CDMO), industrial synthetic products, and cell therapy—we are committed to driving innovation and progress, empowering the healthcare value chain. This partnership reflects our unwavering dedication to ethical practices, labor rights, health and safety, and environmental sustainability. By embedding PSCI principles into our operations, we aspire to work alongside our partners to enhance supply chain outcomes in social, health, safety, and environmental aspects, collectively shaping a more sustainable and responsible future for the global healthcare industry."

GenScript adheres fully to the PSCI principles in advancing responsible supply chain management, encompassing core principles of environment, ethics, labor, health and safety, and management systems. These principles are deeply integrated into GenScript's supply chain management system, allowing for comprehensive multi-dimensional assessments of suppliers to ensure they practice responsible operations, thereby enhancing the compliance and sustainability of the supply chain.

Through its membership in PSCI, GenScript will uphold higher ESG standards in its operations and supply chain management. The company will continue to deepen collaboration with global customers across diverse regulatory environments, solidifying long-term partnerships with its global network of collaborators.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.

Learn more here: https://www.genscript.com


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.